Tag: Essential Medicines List
Relevant publications
Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
Frequently asked questions: Essential medicines for MS
Answers to the most frequently asked questions about our application to add MS treatments to the WHO EML.
MSIF emphasises need for treatments for neurological conditions during WHO meeting
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
Essential medicines for MS
Advocating for the addition of MS treatments to the WHO Essential Medicines List
Our application to the Essential Medicines List
Efforts to improve access to MS treatments continue
The MSIF movement shapes the WHO’s global action plan for epilepsy and other neurological disorders
MSIF highlights priority actions for MS in the draft global plan